You're contacting media contact of this press release

Title: Neuralia TMS Spotlights TMS Therapy Availability at Its Kardinya Location

Australia, 25th Sep 2026 - Neuralia TMS, a trusted mental health service provider, has announced that Transcranial Magnetic Stimulation therapy is available at its Kardinya location. The announcement covers access to TMS therapy for patients in the Kardinya area and surrounding suburbs.Neuralia TMS offers TMS therapy, a non-invasive, drug-free treatment used for conditions including depression, anxiety, PTSD, OCD, chronic pain, and Parkinson's disease. The clinic also provides transcranial Direct Current Stimulation, an at-home neuromodulation therapy, and pharmacogenetic testing to help tailor treatment based on a patient's individual genetic profile. TMS therapy at the Kardinya location is available to patients referred through the standard assessment process the clinic follows for new patients.TMS therapy uses magnetic pulses directed at specific areas of the brain, and is delivered as a course of sessions rather than a single treatment. Neuralia TMS said patients considering TMS therapy typically undergo an initial assessment with the clinic's medical team before a treatment plan is developed, since suitability for TMS depends on a patient's individual history and circumstances. The clinic's pharmacogenetic testing is available to patients as part of this broader assessment process, where genetic information can help inform treatment decisions.Patients are generally referred to Neuralia TMS by a general practitioner or psychiatrist, and the clinic's medical team reviews each referral before an initial consultation is arranged. Neuralia TMS said the Kardinya location follows the same referral and assessment process used across its other locations, so patients in the area are not required to follow a different pathway to access care.A TMS treatment course is delivered...

This press release is issued by King Newswire